"Welcome to Rockville Internal Medicine Group, located in Rockville, MD! Your health and wellness is our number one priority, and we are committed to providing you with the best care possible. Schedule an appointment with us online or call us at (301) 762-5020. You can also access your account, pay a bill, or schedule an appointment using our myPrivia mobile app."

During the past decade, Rockville Internal Medicine Group conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rockville Internal Medicine Group" #1 sponsor was "Gilead Sciences" with 2 trials, followed by "ID Biomedical Corporation, Quebec" with 1 trials sponsored, "ModernaTX, Inc." with 1 trials sponsored, "Oxford Immunotec" with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rockville Internal Medicine Group" #1 collaborator was "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rockville Internal Medicine Group" are "Hypertension" (2 trials), "Arthritis, Rheumatoid" (1 trials), "Influenza" (1 trials), "Influenza, Human" (1 trials) and "Lyme Disease" (1 trials). Many other conditions were trialed in "Rockville Internal Medicine Group" in a lesser frequency.

Most popular intervention types in "Rockville Internal Medicine Group" are "Biological" (3 trials), "Drug" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Darusentan" (2 trials), "Active Comparator: Licensed IIV IIV will be administered as a single dose intramuscularly on Day 1" (1 trials), "Darusentan Placebo" (1 trials), "Experimental: IIV-A Investigational IIV-A will be administered as a single dose intramuscularly on Day 1" (1 trials) and "Experimental: aIIV-B Investigational aIIV-B will be administered as a single dose intramuscularly on Day 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rockville Internal Medicine Group" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Rockville Internal Medicine Group". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Rockville Internal Medicine Group, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Rockville Internal Medicine Group, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".